Today: 17 April 2026
Browse Category

NSE:LT.NS 12 December 2025

Larsen & Toubro (L&T) Share Price Jumps on Goldman Sachs Upgrade: Realty Reshuffle, Order Book Strength and Fresh Analyst Forecasts (Dec 12, 2025)

Larsen & Toubro (L&T) Share Price Jumps on Goldman Sachs Upgrade: Realty Reshuffle, Order Book Strength and Fresh Analyst Forecasts (Dec 12, 2025)

Larsen & Toubro shares jumped near record highs on December 12 after Goldman Sachs upgraded the stock to “Buy” and set a ₹5,000 target, citing growth across business lines and improved margins. The move follows L&T’s recent realty business restructuring. The stock traded around ₹4,109–₹4,114, close to its 52-week high. Goldman expects newer segments like defence and green hydrogen to drive future order inflows.
12 December 2025

Stock Market Today

  • Q4 Earnings Roundup: Intercontinental Exchange and Financial Exchanges Sector Performance
    April 16, 2026, 10:17 PM EDT. The Q4 earnings season for financial exchanges and data providers, including Intercontinental Exchange (NYSE:ICE), showed steady results. The sector delivered revenues 0.8% above analyst consensus on average, reflecting stable trading fees and growing demand for data analytics. Intercontinental Exchange reported $2.50 billion revenue, up 7.8% year-on-year and slightly beating estimates, with shares stable around $165.52. Morningstar (NASDAQ:MORN) led gains with revenue of $641.1 million, up 8.5%, surpassing forecasts by 2.2%, pushing its stock 16.6% higher to $179.61. S&P Global (NYSE:SPGI) posted revenues of $3.92 billion, up 9%, maintaining sector momentum. Challenges remain from regulatory scrutiny and infrastructure costs, but the sector's earnings indicate resilience and ongoing growth opportunities in data-focused financial services.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Go toTop